The Prevalence of Depression in Iranian Women With Breast Cancer: A Meta-Analysis

 Breast cancer is among the most prevalent cancers in women and has mental and emotional effects, leading to declined quality of life. The current this study aimed to determine the prevalence rate of depression in Iranian women with breast cancer.

 This study was conducted using a meta-analysis method at Zabol University of Medical Science in March 2019. Six electronic databases were searched and evaluated for original research papers published on the prevalence of depression in Iranian women with breast cancer. Finally, 15 articles were selected and analysed using Comprehensive Meta-Analysis software.

Overall, the prevalence rate of depression in Iranian women with breast cancer was 18.5% (95% CI: 14.2%-23.7%). The highest reported prevalence of depression in Iranian women with breast cancer was 35% in Babol City, in 2013, (95% CI: 27.8%-43%); the lowest prevalence of depression in this population was measured as 3.4% in Qom City, in 2017 (95% CI:1.2%-9%). A significant correlation was observed between the prevalence rate of depression, and sample size, year, and mean age (P<0.05).

 Depression affects approximately one-fifth of women with breast cancer. Therefore, it is essential for the healthcare staff to treat the physical conditions and psychological disorders associated with breast cancer.